Literature DB >> 9755863

Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex.

I Ventoso1, S E MacMillan, J W Hershey, L Carrasco.   

Abstract

The initiation of translation on eukaryotic mRNA is governed by the concerted action of polypeptides of the eIF-4F complex. One of these polypeptides, eIF-4G, is proteolytically inactivated upon infection with several members of the Picornaviridae family. This cleavage occurs by the action of virus-encoded proteinases: 2Apro (entero- and rhinovirus) or Lpro (aphthovirus). An indirect mode of eIF-4G cleavage through the activation of a second cellular proteinase has been proposed in the case of poliovirus. Although cleavage of eIF4G by rhino- and coxsackievirus 2Apro has been achieved directly in vitro, a similar activity has not been documented to date for poliovirus 2Apro. We report here that a recombinant form of poliovirus 2Apro fused to maltose binding protein (MBP) directly cleaves human eIF-4G from a highly purified eIF-4F complex. Efficient cleavage of eIF-4G requires magnesium ions. The presence of other initiation factors such as eIF-3, eIF-4A or eIF-4B mimics in part the stimulatory effect of magnesium ions and probably stabilizes the cleavage products of eIF-4G generated by 2Apro. These results suggest that efficient cleavage of eIF4G by MBP-2Apro requires a proper conformation of this factor. Finally, MBP-2Apro protein cleaves an eIF-4G-derived synthetic peptide at the same site as rhino- and coxsackievirus 2Apro (R485-G486).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755863     DOI: 10.1016/s0014-5793(98)01027-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 2.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 3.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

Review 4.  Timing Is Everything: Coordinated Control of Host Shutoff by Influenza A Virus NS1 and PA-X Proteins.

Authors:  Denys A Khaperskyy; Craig McCormick
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

Review 5.  Mechanism of translation initiation by Dicistroviridae IGR IRESs.

Authors:  Marla I Hertz; Sunnie R Thompson
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

6.  mRNA translation is compartmentalized to the endoplasmic reticulum following physiological inhibition of cap-dependent translation.

Authors:  Rachel S Lerner; Christopher V Nicchitta
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

Review 7.  Going against the Tide: Selective Cellular Protein Synthesis during Virally Induced Host Shutoff.

Authors:  Shuai Cao; Pragyesh Dhungel; Zhilong Yang
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

8.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

9.  Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1.

Authors:  George A Belov; Gennadiy Kovtunovych; Catherine L Jackson; Ellie Ehrenfeld
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

10.  Genetic selection of poliovirus 2Apro-binding peptides.

Authors:  I Ventoso; A Barco; L Carrasco
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.